Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
✍ Scribed by Rena Vassilopoulou-Sellin; Pamela N. Schultz; Thomas P. Haynie
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 889 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
BACKGROUND. Among patients with well differentiated papillary thyroid carcinoma who generally have an excellent prognosis and a near-normal lifespan, there exist subsets of patients who have significant risk for morbidity and mortality from this disease. It is important to define the patterns of disease progression and the clinical outcome of such patients to develop effective surveillance and treatment strategies. Patients with recurrence after surgery and therapeutic administration of radioactive iodine (MI) for papillary thyroid carcinoma represent one such subset of highrisk patients.
METHODS.
At The University of Texas M. D. Anderson Cancer Center, 65 patients with papillary thyroid carcinoma were diagnosed between 1970 and 1990. Their medical records were reviewed with particular attention to disease recurrence and outcome as well as RAI imaging and treatment.